These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38637187)

  • 1. MRI radiomics predicts the efficacy of EGFR-TKI in EGFR-mutant non-small-cell lung cancer with brain metastasis.
    Qi H; Hou Y; Zheng Z; Zheng M; Sun X; Xing L
    Clin Radiol; 2024 Jul; 79(7):515-525. PubMed ID: 38637187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI radiomics for predicting intracranial progression in non-small-cell lung cancer patients with brain metastases treated with epidermal growth factor receptor tyrosine kinase inhibitors.
    Qu J; Zhang T; Zhang X; Zhang W; Li Y; Gong Q; Yao L; Lui S
    Clin Radiol; 2024 Apr; 79(4):e582-e591. PubMed ID: 38310058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and MRI based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma with brain metastases.
    Qi H; Hou Y; Zheng Z; Zheng M; Qiao Q; Wang Z; Sun X; Xing L
    BMC Cancer; 2024 Mar; 24(1):362. PubMed ID: 38515096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiphases DCE-MRI Radiomics Nomogram for Preoperative Prediction of Lymphovascular Invasion in Invasive Breast Cancer.
    Ma Q; Lu X; Chen Q; Gong H; Lei J
    Acad Radiol; 2024 Dec; 31(12):4743-4758. PubMed ID: 39107190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Events and Survival in Patients With EGFR-Mutant Non-Small Cell Lung Cancer Treated With Osimertinib.
    Lin CY; Chang WT; Su PL; Kuo CW; Yang J; Lin CC; Lin SH
    JAMA Netw Open; 2024 Dec; 7(12):e2448364. PubMed ID: 39636639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of a Nomogram Based on DCE-MRI Radiomics for Predicting Hypoxia-Inducible Factor 1α Expression in Locally Advanced Rectal Cancer.
    Li Z; Huang H; Zhao Z; Ma W; Mao H; Liu F; Yang Y; Wang D; Lu Z
    Acad Radiol; 2024 Dec; 31(12):4923-4933. PubMed ID: 38816315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Risk Factors, and Development and Validation of Prognostic Prediction Models for Distant Metastasis in Patients With Rectal Cancer: A Study Based on the SEER Database and a Chinese Population.
    Zhang H; Wang H; Yao Y; Liu L; Feng F; Li H; Sun C
    Cancer Control; 2024; 31():10732748241303650. PubMed ID: 39579008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term treatment response assessment in non-surgical treatment of advanced non-small cell lung cancer based on radiomics of dual-energy CT.
    Wu X; Lu Y; Huang D; Li Z; Wei C; Li K
    Clin Imaging; 2025 Jan; 117():110362. PubMed ID: 39577032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of anlotinib plus whole brain radiation therapy for patients with NSCLC with multiple brain metastases.
    Gu D; Yu H; Ding N; Xu J; Qian P; Zhu J; Jiang M; Tao H; Zhu X
    Ann Med; 2024 Dec; 56(1):2401618. PubMed ID: 39445449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An arterial spin labeling-based radiomics signature and machine learning for the prediction and detection of various stages of kidney damage due to diabetes.
    Ma F; Shao X; Zhang Y; Li J; Li Q; Sun H; Wang T; Liu H; Zhao F; Chen L; Chen J; Zhou S; Ji Q; Yu P
    Front Endocrinol (Lausanne); 2024; 15():1333881. PubMed ID: 39624821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics-based predictive model for preoperative risk classification of gastrointestinal stromal tumors using multiparametric magnetic resonance imaging: a retrospective study.
    Du J; Yang L; Zheng T; Liu D
    Radiologie (Heidelb); 2024 Nov; 64(Suppl 1):166-176. PubMed ID: 39545983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive progression to EGFR tyrosine kinase inhibitors in advanced NSCLC patients: concomitant mutations, prognostic indicator and subsequent management.
    Wen R; Chen Y; Long J; Huang X; Guo Y; Lin B; Yu Z
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8307-8316. PubMed ID: 37074454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR-Based Radiomics Predicts CDK6 Expression and Prognostic Value in High-grade Glioma.
    Sun C; Jiang C; Wang X; Ma S; Zhang D; Jia W
    Acad Radiol; 2024 Dec; 31(12):5141-5153. PubMed ID: 38964985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study.
    Han JY; Ahn MJ; Lee KH; Lee YG; Kim DW; Min YJ; Kim SW; Cho EK; Kim JH; Lee GW; Lee SS; Lee NM; Jang HW; Han H; Park H; Lee J; Cho BC
    BMC Med; 2024 Oct; 22(1):428. PubMed ID: 39379931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of First-Line Osimertinib and Other EGFR-Tyrosine Kinase Inhibitors on Overall Survival in Untreated Advanced EGFR-Mutated Non-small Cell Lung Cancer in Japan: Updated Data from TREAD Project 01.
    Hibino M; Imamura Y; Shimoyama R; Fukui T; Fukai R; Iwase A; Tamura Y; Chihara Y; Okabe T; Uryu K; Okuda T; Taguri M; Minami H
    Target Oncol; 2024 Nov; 19(6):925-939. PubMed ID: 39302602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periprostatic fat magnetic resonance imaging based radiomics nomogram for predicting biochemical recurrence-free survival in patients with non-metastatic prostate cancer after radical prostatectomy.
    Wu XH; Ke ZB; Chen ZJ; Liu WQ; Xue YT; Chen SH; Chen DN; Zheng QS; Xue XY; Wei Y; Xu N
    BMC Cancer; 2024 Nov; 24(1):1459. PubMed ID: 39604917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osimertinib after definitive chemoradiotherapy in unresectable stage III epidermal growth factor receptor-mutated non-small-cell lung cancer: analyses of central nervous system efficacy and distant progression from the phase III LAURA study.
    Lu S; Ahn MJ; Reungwetwattana T; Özgüroğlu M; Kato T; Yang JC; Huang M; Fujiki F; Inoue T; Quang LV; Sriuranpong V; Vicente D; Fuentes C; Chaudhry AA; Poole L; Armenteros Monterroso E; Rukazenkov Y; van der Gronde T; Ramalingam SS
    Ann Oncol; 2024 Dec; 35(12):1116-1125. PubMed ID: 39289145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of acute pancreatitis severity based on early CT radiomics.
    Qi M; Lu C; Dai R; Zhang J; Hu H; Shan X
    BMC Med Imaging; 2024 Nov; 24(1):321. PubMed ID: 39604925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomics nomogram for the prediction of Ki-67 index in advanced non-small cell lung cancer based on dual-phase enhanced computed tomography.
    Sun H; Zhou P; Chen G; Dai Z; Song P; Yao J
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):9301-9315. PubMed ID: 37204513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.